Cardiovascular Drug Reviews

Changing Times at Cardiovascular Therapeutics
pp. 1-1(1)

Tolerability of High Doses of Lercanidipine versus High Doses of Other Dihydropyridines in Daily Clinical Practice: The TOLERANCE Study
pp. 2-9(8)
Authors: Barrios, Vivencio; Escobar, Carlos; de la Figuera, Mariano; Llisterri, Jose Luis; Honorato, Jesus; Segura, Julián; Calderón, Alberto

Cardioprotective Effect of Vanadyl Sulfate on Ischemia/Reperfusion-Induced Injury in Rat Heart In vivo Is Mediated by Activation of Protein Kinase B and Induction of FLICE-Inhibitory Protein
pp. 10-23(14)
Authors: Bhuiyan, Md. Shenuarin; Takada, Yoko; Shioda, Norifumi; Moriguchi, Shigeki; Kasahara, Jiro; Fukunaga, Kohji

Inhibiting Metalloproteases with PD 166793 in Heart Failure: Impact on Cardiac Remodeling and Beyond
pp. 24-37(14)
Authors: Kaludercic, Nina; Lindsey, Merry L.; Tavazzi, Barbara; Lazzarino, Giuseppe; Paolocci, Nazareno

Use of Antihypertensive Drugs during Pregnancy and Lactation
pp. 38-49(12)
Authors: Ghanem, Firas A; Movahed, Assad

Inhibitors of Advanced Glycation End Products (AGEs): Potential Utility for the Treatment of Cardiovascular Disease
pp. 50-58(9)
Authors: Yamagishi, Sho-ichi; Nakamura, Kazuo; Matsui, Takanori; Ueda, So; Noda, Yoshihiro; Imaizumi, Tsutomu

The Role of Urate and Xanthine Oxidase Inhibitors in Cardiovascular Disease
pp. 59-64(6)
Authors: George, Jacob; Struthers, Allan D.

Inhibition of Acyl-CoA Cholesterol Acyltransferase by F12511 (Eflucimibe): Could it be a New Antiatherosclerotic Therapeutic?
pp. 65-74(10)
Authors: López-Farré, Antonio José; Sacristán, Daniel; Zamorano-León, José J.; San-Martín, Nuria; Macaya, Carlos

Sanguinarine
pp. 75-83(9)
Authors: Mackraj, I.; Govender, Thirumala; Gathiram, Prem

Corrigendum
pp. 84-84(1)